JIANGSU KANION PHARMACEUTICAL CO., LTD. – Trademark Portfolio
Entity Type: 16
JIANGSU KANION PHARMACEUTICAL CO., LTD. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 30 (Staple Foods) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include KANION. The owner is based in JIANGSU.
LIANYUNGANG ECONOMIC & TECHNOLOGICAL DEV
JIANGSU , CN
Showing of trademarks Trademarks
Trademark Classifications
JIANGSU KANION PHARMACEUTICAL CO., LTD.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does JIANGSU KANION PHARMACEUTICAL CO., LTD. have?
JIANGSU KANION PHARMACEUTICAL CO., LTD. has 7 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 abandoned.
What trademark classes does JIANGSU KANION PHARMACEUTICAL CO., LTD. file in?
JIANGSU KANION PHARMACEUTICAL CO., LTD. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are JIANGSU KANION PHARMACEUTICAL CO., LTD.'s most well-known trademarks?
JIANGSU KANION PHARMACEUTICAL CO., LTD.'s registered trademark portfolio includes well-known marks such as KANION. These are among 4 currently registered trademarks in the portfolio.
What is JIANGSU KANION PHARMACEUTICAL CO., LTD.'s trademark registration success rate?
JIANGSU KANION PHARMACEUTICAL CO., LTD. has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.